SCHEMBL4688512

SCHEMBL4688512

CCOc1ccc2c(c1)/C(=C/CNC(=O)CC)CC2

nearest known ligand 0.80

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 9/20 0.80
MTNR1B P49286 8/20 0.80
NQO2 P16083 5/20 0.80
TYMS P04818 1/20 0.42
BRD4 O60885 1/20 0.41
POLB P06746 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
CYP19A1 P11511 2/20 0.40
CYP11B1 P15538 2/20 0.40
CYP11B2 P19099 2/20 0.40
ACACB O00763 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4688517 1.00 MTNR1A (0.80) MTNR1AMTNR1BNQO2TYMSBRD4
SCHEMBL4688514 1.00 MTNR1A (0.80) MTNR1AMTNR1BNQO2TYMSBRD4
SCHEMBL1724138 0.89 MTNR1A (1.00) MTNR1AMTNR1BNQO2CYP19A1CYP11B2
SCHEMBL1724137 0.89 MTNR1A (1.00) MTNR1AMTNR1BNQO2CYP19A1CYP11B2
SCHEMBL1724140 0.89 MTNR1A (1.00) MTNR1AMTNR1BNQO2CYP19A1CYP11B2
SCHEMBL4689415 0.77 MTNR1A (0.78) MTNR1AMTNR1BNQO2NPC1RAB9A
SCHEMBL4689417 0.77 MTNR1A (0.78) MTNR1AMTNR1BNQO2NPC1RAB9A
SCHEMBL4689419 0.77 MTNR1A (0.78) MTNR1AMTNR1BNQO2NPC1RAB9A
SCHEMBL7951201 0.75 MTNR1A (0.75) MTNR1AMTNR1BNQO2CYP19A1CYP11B2
SCHEMBL7951204 0.75 MTNR1A (0.75) MTNR1AMTNR1BNQO2CYP19A1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885210-B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use TAKEDA PHARMACEUTICAL (JP) 2008-06-18 EP disclosed
EP-1550655-A1 Bicyclic intermediates Takeda Pharmaceutical Company Limited (JP) 2005-07-06 EP disclosed
EP-0885210-B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-06-12 EP disclosed
EP-1199304-A1 Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders Takeda Chemical Industries, Ltd. (JP) 2002-04-24 EP disclosed
US-6218429-B1 TREATING MELATONIN RELATED DISORDERS (E.G. CIRCARDIAN RHYTHMS, SLEEP-AWAKE CYCLES, TIME ZONE CHANGES, SLEEP DISORDERS) TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-04-17 US disclosed
US-6034239-A BINDIG TO MELATONIN RECEPTORS; SLEEP DISORDERS; GLANDULAR DISORDERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-03-07 US disclosed
EP-0885210-A1 Tricylic compounds having binding affinity for melatonin receptors, their production and use Takeda Chemical Industries, Ltd. (JP) 1998-12-23 EP disclosed
WO-1997032871-A1 TRICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-09-12 WO disclosed